【会议】第十五届世界药理学大会为丁香园提供10名最低注册费参会名额

只看楼主
页码直达：
直达末页

楼主

丁香园版主

1楼

这个帖子发布于13年零178天前，其中的信息可能已发生改变或有所发展。

值此世界药理学大会在我国北京召开之际，在湖南长沙，世界临床遗传药理学卫星会议亦将同期举行。从2006年6月28日开始，来自全世界20多个国家的近200名从事临床药理，遗传药理，药物基因组学以及新药开发等领域研究的专家学者将汇聚长沙参加这次为期3天的药理学世界盛会。同时，此次大会也是泛太平洋地区临床遗传药理学会（PRACP）2006年会，来自此国际组织的20多名专家亦将来长参会，共同回顾国际临床遗传药理学近年来的成就，探讨未来发展的方向。除了邀请的30个大会报告外，会议还将从递交的文摘中选取13份优秀的青年论文进行大会口头报告，此外大会还安排了Poster交流。这是一次极好的与世界一流学者交流、学习的机会。会议于6月27日开始报到，30日晚上结束。会后将安排市内一日游，毛主席故乡韶山一日游及张家界国家森林公园三日游等旅游活动。

此次大会的主会场定在湖南长沙普瑞温泉酒店（五星），会议房价为388元人民币/间，提供单/双间。4月1日前中国药理学会会员注册费为600元人民币，注册费包含了3天的餐费和会间甜品及闭幕聚餐。4月1日前学生注册费分别为400元人民币（需提供导师推荐信）。详细情况及参会注册请访问会议主页http://www.iuphar2006changsha.com/。国内学者注册请在填写英文注册表前，点击“中国国内用户注册”转至国内注册网页。

此外请通过银行转帐交费注册费、住宿费等相关费用，大会组委会将根据您的注册信息及交费情况为您提前预定酒店房间。银行账户：长沙襄亚药物研究所800113099408093001中国银行湖南省分行

　

如有任何问题请与大会秘书组联系：　

E－mail：iuphar2006cs@yahoo.com.cn

Tel: +86-731-4805380

Fax: +86-731-2354476

您的参会是对我们莫大的支持，我们期待与您共聚长沙！

此致

敬礼!

第15届世界药理学大会长沙卫星会议秘书处

附件：大会日程表

特别说明：此次大会特别为丁香园药学区站友提供10名最低注册费参会名额，即学生早期注册费400/人，这些费用包括大会的所有纸质，电子资料，纪念品，会议三天的交通费和餐饮（五星级酒店）。同时为药学区版主提供1－2名免注册费参会名额。请大家关注药学区的报名活动。

＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝
有意参加的丁香园战友可以请将个人信息email至如下邮箱：dxytemp@56.com。斑竹将会根据您的个人信息进行审核，并给予您明确的回复。

email格式如下：

DXY ID：
DXY 得分：
真实姓名：
学历：
从事专业及年限
工作单位：
通讯地址：
电话（座机、手机）：
＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝

邀请讨论

搜索

2006-04-25 15:02 浏览 : 35677 回复 : 31

投票
收藏 3
打赏
引用
分享
- 微信扫一扫
- 新浪微博
- 丁香客
- 复制网址
举报
- 广告宣传推广
- 政治敏感、违法虚假信息
- 恶意灌水、重复发帖
- 违规侵权、站友争执
- 附件异常、链接失效
- 其他

逃编辑于 2006-04-26 17:58

• 丁香早知道 - 10.16 | 规培对我没用，却为了中级职称要耗掉4年时间！

楼主

逃

神经科

丁香园版主

2楼

附：第15届世界药理大会长沙卫星会议日程表

June 28, 2006, Wednesday

8:30-8:35
Opening Remarks

Hong-Hao Zhou, MD
Chair, Organization Committee of IUPHAR Changsha Satellite Meeting
Professor and Director, Pharmacogenetics Research Institute, Central South University, China

8:35-9:25
Keynote Lecture

Chair: Leif Bertilsson, PhD
Professor, Department of Laboratory Medicine, Division of Clinical Pharmacology, Huddinge University Hospital, Sweden

Pharmacogenetics - five decades of therapeutic lessons from genetic diversity
Urs A Meyer, MD
Professor, Division of Pharmacology/Neurobiology, Biozentrum of the University of Basel, Switzerland

9:25-9:35
Café break

9:35-12:35
Session 1: Racial and ethnic diversity in drug response and disposition

Chair: Alastair J Wood, MD
Professor and Associate Dean, Department of Medicine and Pharmacology, Vanderbilt University, USA

Co-Chair: Guo-Wei Sang, PhD
Professor and Director, National Institute for the Control of Pharmaceutical and biological Products, China

9:35-10:10
Polymorphism of CYP2D6, IL1b, etc.
Leif Bertilsson, PhD
Professor, Department of Laboratory Medicine, Division of Clinical Pharmacology, Huddinge University Hospital, Sweden

10:10-10:45
Genetic-environmental interactions that influence on the ethnic diversity of drug responses
Jae-Gook Shin, MD, PhD
Professor, Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Clinical Pharmacology Center, Busan Paik Hospital, Korea

10:45-11:20
Ethnicity, culture and pharmacogenomics
Keh-Ming Lin, PhD
Professor, Department of Psychiatry, Harbor-UCLA Medical Center, USA

11:20-11:55
Genetic mechanism of ethnic differences in drug disposition and response
Hong-Hao Zhou, MD
Chair, Organization Committee of IUPHAR Changsha Satellite Meeting
Professor and Director, Pharmacogenetics Research Institute, Central South University, China

11:55-12:35
Two selected speakers from submitted abstracts
Each one will present for 20 minutes including discussion

12:50-13:50
Luncheon Seminar

Chair: Leaf Huang, PhD
Professor, Division of Molecular Pharmaceutics, School of Pharmacy, University of North Carolina, USA

Calcimimetics and the treatment of secondary hyperparathyroidism
L. Darryl Quarles, MD
Professor and Director, the Kidney Institute & Division of Nephrology, University of Kansas Medical Center, USA

13:50-14:15
Post and Exhibition Viewing

14:15-15:05
Plenary Lecture
Chair: Junichi Azuma, PhD
Chairman of Scientific Committee of PRACP
Professor, Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Japan

The Drug and Nuclear Receptor Regulation of the CYP2Cs
Joyce A Goldstein, PhD
Professor and Director, Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, USA
15:05-15:15
Café Break

15:15-18:00
Session 2: Pharmacogenetics in international drug development and clinical trial

Chair: Lawrence J Lesko, PhD
FCP Director, Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug Evaluation and Research, USA

Co-Chair: Steve Leeder, PharmD, PhD, DABCP
Chief of Section of Developmental Pharmacology and Experimental Therapeutics, Division of Clinical Pharmacology and Medical Toxicology, Children's Mercy Hospital and Clinics, Pediatrics and Pharmacology, University of Missouri-Kansas City, USA

15:15-15:50
Developmental and Pediatric Pharmacogenomics - Why is This Relevant to Rational Drug Development?
Steve Leeder, PharmD, PhD, DABCP

15:50-16:25
Pharmacogenomics on Pharmaceutical Science in Japan
Kyoichi Ohashi, MD, PhD
Professor of Clinical Pharmacology, Oita University Faculty of Medicine, Director of
Clinical Pharmacology Center, Oita University Hospital, Japan

16:25-17:00
Regulatory Perspective on Integrating Pharmacogenomics into Drug Development and Regulatory Decision
Lawrence J Lesko, PhD, F.C.P.
Professor and Director, Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug Evaluation and Research, Food and Drug Administration, USA

17:00-18:00
Three selected speakers from submitted abstracts
Each one will present for 20 minutes including discussion

18:15-20:00
Special Dinner

June 29, 2006, Thursday

8:30-9:20
Plenary Lecture

Chair: Kazutaka Shimoda, PhD
Professor, Dokkyo University School of Medicine, Japan

Pharmacogenetics in the Americas: impact of genetic admixture
Guilherme Suarez-Kurtz, MD
Professor and Director, Pharmacology Division, Instituto Nacional de Câncer, Brazil

9:20-9:30
Café Break

9:30-12:15
Session 3: Pharmacogenetics and genotype directed tailored pharmacotherapy

Chair: Julia Kirchheiner, MD
Professor, Department of Pharmacology of Natural Products & Clinical Pharmacology, University of Ulm, Germany

Co-Chair: Kyoichi Ohashi, MD, PhD
Professor of Clinical Pharmacology, Oita University Faculty of Medicine, Director of Clinical Pharmacology Center, Oita University Hospital, Japan

9:30-10:05
Pharmacogenetics-based therapy with anticoagulants
Ann K. Daly, PhD
Professor, School of Clinical and Laboratory Sciences, University of Newcastle Medical School, UK

10:05-10:40
Genetic polymorphism of FMO3 associated with trimethylaminuria (fish-odor syndrome)
Hiroshi Yamazaki, PhD
Professor, Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Japan

10:40-11:15
CYP2C9 genotypes and pharmacogenetics-based individualization of drug therapy
Julia Kirchheiner, MD
Professor, Department of Pharmacology of Natural Products & Clinical Pharmacology, University of Ulm, Germany

11:15-12:15
Three selected speakers from submitted abstracts
Each one will present for 20 minutes including discussion.

12:30-13:30
Luncheon Seminar
Chair: Ann K. Daly, PhD
Professor, School of Clinical and Laboratory Sciences, University of Newcastle Medical School, UK

Pharmacogenomics---what can it do for us?
Alastair J Wood, MD
Professor and Associate Dean, Department of Medicine and Pharmacology, Vanderbilt University, USA

14:00-14:50
Plenary Lecture

Chair: Guilherme Suarez-Kurtz, MD
Professor and Director, Pharmacology Division, Instituto Nacional de Câncer, Brazil

Pharmacogenomics-based eradication therapy of Helicobacter pylori infection-
An up-to-date proposal
Takashi Ishizaki, PhD
Professor, Department of Clinical Pharmacology and Pharmacy, School of Pharmaceutical Sciences Teikyo Heisei University, Japan

14:50-15:00
Café Break

15:00-18:00
Session 4: Pharmacogenetics in patient care

Chair: Michel Eichelbaum, PhD
Professor, Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Germany

Co-Chair: Vural Ozdemir, MD, PhD
Professor and Deputy Director for Research and Development, College of Medicine, University of California Irvine, USA

15:00-15:35
Pharmacogenetics, Ethics and Expectations: Lessons from Science and Technology Studies
Adam M Hedgecoe, PhD
Professor, Department of Sociology, School of Social Sciences, University of Sussex, UK

15:35-16:10
Pharmacogenetics of anticonvulsants
Ingolf Cascorbi, PhD
Professor and Chair of Pharmacology, University Hospital Schleswig-Holstein, Germany

16:10-16:45
Pharmacogenomics of dopamine and serotonin neurotranmitor systems
Nakao Iwata, MD
Professor, Department of Psychiatry, Fujita Health University School of Medicine，Japan

16:45-17:20
Gene therapy: a possible consequence of pharmacogenetics?
Leaf Huang, PhD
Professor, Division of Molecular Pharmaceutics, School of Pharmacy, University of North Carolina, USA

17:20-18:00
Two selected speakers from submitted abstracts
Each one will present for 20 minutes including discussion

June 30 , 2006, Friday

8:30-9:20
Plenary Lecture

Chair: John Miners, PhD, DSc
Professor, Department of Pharmacology, Flinders Medical Center, Flinders University of South Australia, Australia

Pharmacogenomics- present limitations and the way forward
Michel Eichelbaum, PhD
Professor, Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Germany

9:20-9:30
Café Break

9:30-12:15
Session 5: New Technology in drug discovery and development

Chair: Siu Wa Tang, PhD
Professor, Department of Psychiatry, Faculty of Medicine, University of Hong Kong, China

Co-Chair: Min-Soo Lee, MD, PhD
Professor, Department of Psychiatry, Anam Hospital, Korea University College of Medicine, Korea

9:30-10:05
Computational tools for prediction of functional sequence elements
Anna Di Rienzo, PhD
Associate Professor, Department of Human Genetics, University of Chicago, USA

10:05-10:40
Standardizing global gene expression analysis
Theo K Bammler, PhD
Professor, Bioinformatics Coordinator, Center for Ecogenetics and Environmental Health
University of Washington, USA

10:40-11:15
New technology in drug discovery
Siu Wa Tang, PhD
Professor, Department of Psychiatry, Faculty of Medicine, University of Hong Kong, China

11:15-12:15
Three selected speakers from submitted abstracts
Each one will present for 20 minutes including discussion

12:30-13:30
Luncheon Seminar

Chair: Tetsuya Kamataki, PhD
Professor, Laboratory of Drug Metabolism, Division of Pharmacobiodynamics, Graduate School of Pharmaceutical Sciences, Hokkaido University, Japan

Title To be confirmed
C. Michael Stein, MD
Editor, Clinical Pharmacology and Therapeutics
Associate Professor, School of Medicine, Vanderbilt University, USA

13:30-14:00
Café Break

14:00-18:00
Workshop：Integration of Genetic Variation in Pharmacokinetics and Molecular Targets

Chair: Toshiyuki Someya, MD, PhD
President of PRACP，Professor and Chairman, Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Japan

Co-Chair: Christopher Reist, MD
Professor, Department of Psychiatry and Human Behavior College of Medicine, University of California Irvine, Biomarker and Clinical Pharmacology Unit, VA Long Beach Healthcare System, USA

14:00-14:40
Genetic polymorphism of UGT
John Miners, PhD, DSc
Professor, Department of Pharmacology, Flinders Medical Center, Flinders University of South Australia, Australia

14:40-15:20
Pharmacogenetics of psychotropic drugs
Toshiyuki Someya, MD, PhD
President of PRACP，Professor and Chairman, Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Japan

15:20-16:00
Pharmacogenomics of aspirin induced asthma
Hae Sim Park, PhD
Professor, Department of Allergy and Rheumatology, Ajou University School of Medicine, Korea

16:00-16:40
Biomarkers of atypical antipsychotic safety: contribution of cyp2d6 and dopamine d2
receptor genes
Christopher Reist, PhD
Professor, Department of Psychiatry and Human Behavior College of Medicine, University of California Irvine, Biomarker and Clinical Pharmacology Unit, VA Long Beach
Healthcare System, USA

16:40-17:20
Novel genetic polymorphism of CYP2D6 and CYP2A6 analyzing genes from patients
showing "abnormal" phenotype to drugs
Tetsuya Kamataki, PhD
Professor, Laboratory of Drug Metabolism, Division of Pharmacobiodynamics, Graduate School of Pharmaceutical Sciences, Hokkaido University, Japan

17:20-18:00
Wrap up talk

How to integrate pharmacokinetics and molecular drug target genetic variation in study design
Magnus Ingelman-Sundberg, PhD
Professor, Division of Molecular Toxicology, Karolinska Institute, Sweden

18:00
Awarding Ceremony

Closing Remarks

Toshiyuki Someya, MD, PhD
President of PRACP
Professor and Chairman, Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Japan

2006-04-25 15:03